Observe Medical ASA – Primary insider notice
Reference is made to Observe Medical ASA's (the "Company") stock exchange announcement on 6 July 2020 regarding the final result in the in the rights issue of 4,090,909 new shares in the Company (the "Offer Shares") at a subscription price of NOK 11.00 per share (the "Rights Issue"). Navamedic ASA ("NAVA"), represented at the Company's board of directors by Kathrine Gamborg Andreassen, has today, on 6 July 2020, received notice of its allocation of 1,022,727 Offer Shares in the Rights Issue. Following allocation of the Offer shares, NAVA, with its related parties, owns 4,222,727